Global Search

    Showing 1081-1090 of 2773 results for

  • Clinical Trial
    https://mdmercy.com/en/About-Mercy/News-and-Media/Research-and-Clinical-Trials/Aspen
    Topic of Study: Breast Cancer This is a randomized Phase III trial comparing active symptom monitoring plus patient education versus patient education alone to improve persistence with endocrine therapy in young women with Stage I-III breast cancer (Aspen). (Clinicaltrials.gov ID#: NCT05568472)
  • Clinical Trial
    https://mdmercy.com/en/About-Mercy/News-and-Media/Research-and-Clinical-Trials/CAPItello-292
    Topic of Study: Breast Cancer This is a Phase Ib/III, open-label, randomised study of Capivasertib plus CDK4/6 inhibitors and Fulvestrant versus CDK4/6 inhibitors and Fulvestrant in Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative locally advanced, unresectable or metastatic breast cancer. (Clinicaltrials.gov ID#: NCT04862663)
  • Clinical Trial
    https://mdmercy.com/en/About-Mercy/News-and-Media/Research-and-Clinical-Trials/CO44194
    Topic of Study: Breast Cancer This is a study of RO7247669 + Nab-Paclitaxel Compared With Pembrolizumab + Nab-Paclitaxel in participants with previously untreated, PD-L1-Positive, locally-advanced unresectable or metastatic Triple-Negative breast cancer. (Clinicaltrials.gov ID#: NCT05852691)
  • Clinical Trial
    https://mdmercy.com/en/About-Mercy/News-and-Media/Research-and-Clinical-Trials/CorEvitas
    Topic of Study: Inflammatory Bowel Disease The goals of this prospective cohort study are to study the natural history of IBD, prevalence and incidence of comorbidities, and targeted adverse events, as well as utilization patterns and comparative effectiveness and safety of approved IBD treatments. (Clinicaltrials.gov ID#: NCT03162549).
  • Clinical Trial
    https://mdmercy.com/en/About-Mercy/News-and-Media/Research-and-Clinical-Trials/EMPOWER-IBD
    Topic of Study: Inflammatory Bowel Disease This is a multicenter, prospective randomized controlled trial in which adults with IBD are randomized to four IBD self-help interventions to determine the impact of the interventions on patients' physical and psychosocial function and self-efficacy.
  • Clinical Trial
    https://mdmercy.com/en/About-Mercy/News-and-Media/Research-and-Clinical-Trials/evERA
    Topic of Study: Breast Cancer This is a Phase III, randomized, open-label, multicenter study evaluating the efficacy and safety of Giredestrant plus Everolimus compared with the physician's choice of endocrine therapy plus Everolimus in patients with estrogen receptor-positive, HER2-negative, locally advanced or metastatic breast cancer. (Clinicaltrials.gov ID#: NCT05306340)
  • Clinical Trial
    https://mdmercy.com/en/About-Mercy/News-and-Media/Research-and-Clinical-Trials/MONITOR
    Topic of Study: Inflammatory Bowel Disease This is a 6-month, multicenter prospective trial to assess the feasibility and effectiveness of a remote monitoring digital health system on adherence, clinical outcomes, and healthcare utilization for patients with Crohn's Disease or Ulcerative Colitis who are beginning treatment with either IV or subcutaneous vedolizumab.
  • Clinical Trial
    https://mdmercy.com/en/About-Mercy/News-and-Media/Research-and-Clinical-Trials/Quotient
    Topic of Study: Inflammatory Bowel Disease This is a pragmatic, open-label, multicenter randomized controlled trial conducted in asymptomatic patients with IBD who have persistent moderate to severe endoscopic inflammation despite optimization of index targeted immunomodulatory (TIM). This clinical trial aims to collect and analyze data in patients with IBD who are currently receiving IBD medication(s) that targets their immune system (TIM) in routine clinical care, and to determine if switching to an alternative IBD medications will improve their disease outcome without increasing the burden of their treatment. (Clinicaltrials.gov ID# NCT05230173)
  • Clinical Trial
    https://mdmercy.com/en/About-Mercy/News-and-Media/Research-and-Clinical-Trials/RO7790121
    Topic of Study: Inflammatory Bowel Disease This is a phase III, multicenter, double-blind, placebo-controlled, treat-through study. The goals of this clinical trial are to evaluate the efficacy and safety of RO7790121 compared with placebo in inducing and maintaining remission in patients with moderately to severely active Crohn's Disease and Ulcerative colitis.
  • Clinical Trial
    https://mdmercy.com/en/About-Mercy/News-and-Media/Research-and-Clinical-Trials/SPARC-IBD
    Topic of Study: Inflammatory Bowel Disease The goals of this study are to create a prospective cohort of well phenotyped adult IBD patients with serial clinical and patient reported data and biosamples collected throughout the course of their disease. This data will be used to identify predictors of response to IBD therapies and of disease relapse.